Northern Trust’s Amgen AMGN Stock Holding History

Northern Trust’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.19B	Buy	6,217,838 +36,180	+0.6%	+$12.9M	0.29%	58
2025 Q4	$2.02B	Buy	6,181,658 +37,178	+0.6%	+$11.8M	0.26%	66
2025 Q3	$1.73B	Buy	6,144,480 +2,711	+0%	+$786K	0.22%	79
2025 Q2	$1.71B	Sell	6,141,769 -64,298	-1%	-$18.2M	0.24%	72
2025 Q1	$1.93B	Sell	6,206,067 -224,962	-3%	-$66.4M	0.29%	55
2024 Q4	$1.68B	Buy	6,431,029 +875,254	+16%	+$260M	0.24%	67
2024 Q3	$1.79B	Sell	5,555,775 -297,007	-5%	-$97.2M	0.29%	54
2024 Q2	$1.83B	Sell	5,852,782 -163,852	-3%	-$48.1M	0.31%	53
2024 Q1	$1.71B	Sell	6,016,634 -396,388	-6%	-$116M	0.3%	57
2023 Q4	$1.85B	Sell	6,413,022 -564,603	-8%	-$154M	0.33%	49
2023 Q3	$1.88B	Buy	6,977,625 +255,463	+4%	+$63.8M	0.36%	45
2023 Q2	$1.49B	Sell	6,722,162 -228,015	-3%	-$52.9M	0.29%	61
2023 Q1	$1.68B	Sell	6,950,177 -157,599	-2%	-$38.7M	0.33%	51
2022 Q4	$1.87B	Sell	7,107,776 -53,851	-0.8%	-$14.4M	0.39%	42
2022 Q3	$1.61B	Sell	7,161,627 -125,680	-2%	-$30.5M	0.37%	46
2022 Q2	$1.77B	Sell	7,287,307 -344,416	-5%	-$84.4M	0.38%	49
2022 Q1	$1.85B	Sell	7,631,723 -44,410	-0.6%	-$10.2M	0.32%	54
2021 Q4	$1.73B	Sell	7,676,133 -156,508	-2%	-$33M	0.28%	67
2021 Q3	$1.67B	Buy	7,832,641 +253,637	+3%	+$58.4M	0.29%	62
2021 Q2	$1.85B	Sell	7,579,004 -168,789	-2%	-$41.5M	0.33%	60
2021 Q1	$1.93B	Sell	7,747,793 -172,772	-2%	-$41.2M	0.36%	53
2020 Q4	$1.82B	Sell	7,920,565 -217,616	-3%	-$50.2M	0.35%	54
2020 Q3	$2.07B	Buy	8,138,181 +159,771	+2%	+$39.6M	0.45%	43
2020 Q2	$1.88B	Sell	7,978,410 -4,782	-0.1%	-$1.09M	0.45%	43
2020 Q1	$1.62B	Sell	7,983,192 -43,183	-0.5%	-$9.43M	0.46%	42
2019 Q4	$1.93B	Sell	8,026,375 -650,425	-7%	-$143M	0.43%	42
2019 Q3	$1.68B	Sell	8,676,800 -149,575	-2%	-$28.7M	0.4%	47
2019 Q2	$1.63B	Sell	8,826,375 -100,897	-1%	-$18.1M	0.39%	48
2019 Q1	$1.7B	Sell	8,927,272 -254,778	-3%	-$48.7M	0.42%	42
2018 Q4	$1.79B	Buy	9,182,050 +408,675	+5%	+$79.7M	0.5%	37
2018 Q3	$1.82B	Sell	8,773,375 -296,777	-3%	-$58.5M	0.45%	39
2018 Q2	$1.67B	Sell	9,070,152 -174,054	-2%	-$30.8M	0.43%	40
2018 Q1	$1.58B	Sell	9,244,206 -541,066	-6%	-$99.3M	0.41%	44
2017 Q4	$1.7B	Buy	9,785,272 +44,671	+0.5%	+$7.91M	0.43%	44
2017 Q3	$1.82B	Buy	9,740,601 +457,884	+5%	+$81.1M	0.47%	39
2017 Q2	$1.6B	Sell	9,282,717 -160,605	-2%	-$26.1M	0.45%	41
2017 Q1	$1.55B	Buy	9,443,322 +110,512	+1%	+$18.4M	0.45%	40
2016 Q4	$1.36B	Sell	9,332,810 -240,425	-3%	-$36.2M	0.42%	42
2016 Q3	$1.6B	Buy	9,573,235 +234,821	+3%	+$39.7M	0.5%	35
2016 Q2	$1.42B	Sell	9,338,414 -264,752	-3%	-$41.2M	0.46%	43
2016 Q1	$1.44B	Buy	9,603,166 +35,188	+0.4%	+$5.23M	0.48%	42
2015 Q4	$1.55B	Sell	9,567,978 -716,691	-7%	-$113M	0.51%	34
2015 Q3	$1.42B	Sell	10,284,669 -532,033	-5%	-$83.9M	0.47%	40
2015 Q2	$1.66B	Buy	10,816,702 +156,825	+1%	+$25.1M	0.5%	34
2015 Q1	$1.7B	Sell	10,659,877 -190,069	-2%	-$29.9M	0.51%	32
2014 Q4	$1.73B	Buy	10,849,946 +30,500	+0.3%	+$4.75M	0.52%	32
2014 Q3	$1.52B	Sell	10,819,446 -216,053	-2%	-$28.2M	0.48%	36
2014 Q2	$1.31B	Buy	11,035,499 +9,331	+0.1%	+$1.08M	0.41%	45
2014 Q1	$1.36B	Sell	11,026,168 -320,242	-3%	-$38.8M	0.43%	43
2013 Q4	$1.29B	Buy	11,346,410 +72,777	+0.6%	+$8.28M	0.42%	46
2013 Q3	$1.26B	Sell	11,273,633 -466,096	-4%	-$50.5M	0.44%	38
2013 Q2	$1.16B	Buy	+11,739,729	New	+$1.22B	0.42%	40

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust's AMGN Position: Q1 2026 in Review

Northern Trust increased its Amgen (AMGN) stake by 0.59% in Q1 2026, buying an estimated $12.9M and bringing the position to 6,217,838 shares worth $2.19B. The position accounts for 0.29% of the portfolio, ranked #58.

Northern Trust first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Northern Trust held 6,217,838 shares of Amgen worth $2.19B as of Q1 2026.
Northern Trust bought 36,180 Amgen shares in Q1 2026, an estimated $12.9M.
Amgen made up 0.29% of Northern Trust's portfolio in Q1 2026, its #58 holding.
Northern Trust first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.